143 related articles for article (PubMed ID: 10313737)
1. Acne drug controversy ignites turf battle over prescribing.
Thomas P
Med World News; 1988 Jun; 29(11):46-7. PubMed ID: 10313737
[No Abstract] [Full Text] [Related]
2. A pox on your practice. iPLEDGE program scars dermatologists.
Ortolon K
Tex Med; 2006 May; 102(5):29-31. PubMed ID: 17115578
[No Abstract] [Full Text] [Related]
3. Anti-acne drug poses dilemma for FDA.
Sun M
Science; 1988 May; 240(4853):714-5. PubMed ID: 2966438
[No Abstract] [Full Text] [Related]
4. FDA ponders approaches to curbing adverse effects of drug used against cystic acne.
Marwick C
JAMA; 1988 Jun; 259(22):3225. PubMed ID: 2967382
[No Abstract] [Full Text] [Related]
5. [Treatment of severe acne with isotretinoin].
Raymond GP
Union Med Can; 1984 Jun; 113(6):448-51. PubMed ID: 6237477
[No Abstract] [Full Text] [Related]
6. Update on isotretinoin (Accutane) for acne.
Med Lett Drugs Ther; 1983 Nov; 25(649):105-6. PubMed ID: 6227800
[No Abstract] [Full Text] [Related]
7. Is topical tretinoin safe during the first trimester?
Shapiro L; Pastuszak A; Curto G; Koren G
Can Fam Physician; 1998 Mar; 44():495-8. PubMed ID: 9559187
[TBL] [Abstract][Full Text] [Related]
8. Accutane risk management program strengthened.
FDA Consum; 2002; 36(1):8. PubMed ID: 11881607
[No Abstract] [Full Text] [Related]
9. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
Doshi A
Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
[No Abstract] [Full Text] [Related]
10. Isotretinoin for acne: the experience broadens.
Pochi PE
N Engl J Med; 1985 Oct; 313(16):1013-4. PubMed ID: 2931602
[No Abstract] [Full Text] [Related]
11. Moral dilemma: two views.
Pedulla DM
Postgrad Med; 1986 May; 79(6):34-5. PubMed ID: 2939403
[No Abstract] [Full Text] [Related]
12. Revisions in isotretinoin labeling.
FDA Drug Bull; 1985 Aug; 15(2):20-1. PubMed ID: 2932358
[No Abstract] [Full Text] [Related]
13. Acne and accutane.
Burton CS; Eyre RW; Callaway JL
N C Med J; 1984 Aug; 45(8):513. PubMed ID: 6236375
[No Abstract] [Full Text] [Related]
14. Accutane (isotretinoin) revisited: severe birth defects from acne therapy.
Hansen RC
Ariz Med; 1985 Jun; 42(6):363-5. PubMed ID: 3161486
[No Abstract] [Full Text] [Related]
15. Multiple congenital defects associated with maternal use of topical tretinoin.
Lipson AH; Collins F; Webster WS
Lancet; 1993 May; 341(8856):1352-3. PubMed ID: 8098487
[No Abstract] [Full Text] [Related]
16. [Teratogenicity of isotretinoin].
Orfanos CE
Hautarzt; 1984 Oct; 35(10):503-5. PubMed ID: 6238920
[No Abstract] [Full Text] [Related]
17. Birth defects caused by isotretinoin--New Jersey.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1988 Mar; 37(11):171-2, 177. PubMed ID: 3126387
[No Abstract] [Full Text] [Related]
18. Teratogenicity of isotretinoin.
Rosa FW
Lancet; 1983 Aug; 2(8348):513. PubMed ID: 6136666
[No Abstract] [Full Text] [Related]
19. Isotretinoin prescribing: finding a balance between benefit and risk.
Stern RS
Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):611-3. PubMed ID: 16134100
[No Abstract] [Full Text] [Related]
20. Pharmacists and the right to prescribe: ugly "turf" battle or opportunity for improved patient care.
Uzych L
J Fla Med Assoc; 1988 Mar; 75(3):143-4. PubMed ID: 3361275
[No Abstract] [Full Text] [Related]
[Next] [New Search]
